Acquiring Company
Astellas
Acquired Company
Propella Therapeutics, Inc.
PittsboroBiotechnologyHealth CareMedicalPharmaceuticalPharmaceutical ManufacturingPharmaceutical ManufacturingDescription
Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") announced today that it has completed the acquisition of Propella Therapeutics, Inc. (President and CEO: William Moore, "Propella"), and has become a wholly owned subsidiary of Astellas as of U.S. Eastern Time December 21, 2023.
Other recent acquisitions in Medical and Pharmaceutical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Astellas To Acquire Propella Therapeutics (November 15, 2023)
- Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio (January 23, 2024)
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics (January 18, 2024)
- Lilly Completes Acquisition Of Point Biopharma (December 27, 2023)
- Versiti Acquires Indianapolis-Based Pearl Pathways (November 7, 2023)
- InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain (January 31, 2024)
Who to call at Astellas, and when
When Astellas changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Astellas raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Astellas, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Astellas. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Astellas makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Propella Therapeutics, Inc.?
Propella Therapeutics, Inc. was acquired by Astellas. The deal was reported on December 21, 2023. Astellas Pharma US, Inc. is an affiliate of Tokyo-based Astellas Pharma Inc., a top 20 global pharmaceutical research company. Astellas is privately held and operates in Biotechnology.
When did Astellas acquire Propella Therapeutics, Inc.?
Astellas's acquisition of Propella Therapeutics, Inc. was reported on December 21, 2023. Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") announced today that it has completed the acquisition of Propella Therapeutics, Inc. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Propella Therapeutics, Inc. do?
We are a privately held development-stage company dedicated to bringing to market best-in-class drugs that utilize an active ingredient with a known mechanism of action. It is privately held, operating in Pharmaceutical Manufacturing, and is based in Pittsboro.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.